PE20110836A1 - Sintesis de morfina-6-glucoronido - Google Patents

Sintesis de morfina-6-glucoronido

Info

Publication number
PE20110836A1
PE20110836A1 PE2011001187A PE2011001187A PE20110836A1 PE 20110836 A1 PE20110836 A1 PE 20110836A1 PE 2011001187 A PE2011001187 A PE 2011001187A PE 2011001187 A PE2011001187 A PE 2011001187A PE 20110836 A1 PE20110836 A1 PE 20110836A1
Authority
PE
Peru
Prior art keywords
formula
dimorphin
ilo
diyl
compound
Prior art date
Application number
PE2011001187A
Other languages
English (en)
Inventor
Alain Dlubala
Isabelle Ripoche
Claire Trecant
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PE20110836A1 publication Critical patent/PE20110836A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

REFERIDA A UN PROCEDIMIENTO PARA PREPARAR MORFINA-6-GLUCURONIDO O UNO DE SUS DERIVADOS, DONDE DICHO PROCEDIMIENTO CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (I) CON UN DERIVADO DE ACIDO GLUCURONIDO DE FORMULA (II), EN PRESENCIA DE UN DISOLVENTE AROMATICO QUE TIENE UN PUNTO DE FUSION MENOR O IGUAL A -20ºC TAL COMO CLOROBENCENO, TOLUENO, 1,2-DICLOROBENCENO, 1,3,5-TRIFLUOROBENCENO O MESITILENO Y DE TRIFLUOROMETANOSULFONILO DE TRIMETILSILANO, HACIENDO REACCIONAR EL PRODUCTO OBTENIDO CON UN AGENTE FUERTEMENTE BASICO TAL COMO SOSA PARA LUEGO RECUERAR EL PRODUCTO RESULTANTE, DONDE R1 ES CARBONILO O COR5CO; R5 ES ALCANO(C1-C4)-DIILO, ALQUENO(C2-C4)-DIILO, ALQUINO(C2-C4)-DIILO, ENTRE OTROS; PG ES ACETILO, ISOBUTIRILO, BENZOILO O PIVALOILO; X ES TRIHALOGENOACETAMIDATO; R4 ES ALQUILO(C1-C4)CARBOXILATO. EL COMPUESTO DE FORMULA (I) ES TEREFTALATO DE DIMORFIN-3-ILO, ISOFTALATO DE DIMORFIN-3-ILO, FUMARATO DE DIMORFIN-3-ILO, ENTRE OTROS Y EL COMPUESTO DE FORMULA (II) ES TRICLOROACETIMIDATO DE 2,3,4-TRI-O-ACETIL-ALFA-D-GLUCOPIRANOSILURONATO DE METILO
PE2011001187A 2008-12-10 2009-12-08 Sintesis de morfina-6-glucoronido PE20110836A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806948A FR2939436B1 (fr) 2008-12-10 2008-12-10 Synthese de morphine-6-glucuronide ou de l'un de ses derives

Publications (1)

Publication Number Publication Date
PE20110836A1 true PE20110836A1 (es) 2011-11-25

Family

ID=40996840

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011001187A PE20110836A1 (es) 2008-12-10 2009-12-08 Sintesis de morfina-6-glucoronido

Country Status (31)

Country Link
US (1) US8258298B2 (es)
EP (1) EP2376496B1 (es)
JP (1) JP5619768B2 (es)
KR (1) KR20110091534A (es)
CN (1) CN102307876B (es)
AR (1) AR074513A1 (es)
AU (1) AU2009326906B2 (es)
BR (1) BRPI0923238A2 (es)
CA (1) CA2746428A1 (es)
CL (1) CL2011001398A1 (es)
CO (1) CO6390060A2 (es)
CR (1) CR20110307A (es)
EA (1) EA201170790A1 (es)
EC (1) ECSP11011100A (es)
ES (1) ES2470666T3 (es)
FR (1) FR2939436B1 (es)
HK (1) HK1163096A1 (es)
HN (1) HN2011001597A (es)
IL (1) IL213379A0 (es)
MA (1) MA32950B1 (es)
MX (1) MX337925B (es)
MY (1) MY152276A (es)
NI (1) NI201100116A (es)
NZ (1) NZ593342A (es)
PE (1) PE20110836A1 (es)
SG (1) SG172069A1 (es)
TN (1) TN2011000243A1 (es)
TW (1) TW201033218A (es)
UA (1) UA103643C2 (es)
WO (1) WO2010067007A2 (es)
ZA (1) ZA201104657B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020012248A1 (en) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Novel naphthylenyl compounds for long-acting injectable compositions and related methods
WO2020012245A1 (en) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Thienothiophene-naltrexone prodrugs for long-acting injectable compositions
WO2020094634A1 (en) 2018-11-05 2020-05-14 Alkermes Pharma Ireland Limited Thiophene prodrugs of naltroxene for long-acting injectable compositions and related methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) * 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
GB2339196B (en) 1997-04-14 2001-11-07 Salford Ultrafine Chem & Res Morphine derivatives
ES2185350T3 (es) * 1998-06-06 2003-04-16 Cenes Ltd Sintesis de morfina-6-glucuronido.
GB9914382D0 (en) * 1999-06-21 1999-08-18 Ufc Limited New process for the manufacture of morphine-6-glucuronide and its analogues and also to a manufacture of new intermediaries
TWI255186B (en) * 2001-06-05 2006-05-21 Control Delivery Sys Inc Sustained-release analgesic compounds
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
KR20050008658A (ko) * 2002-03-19 2005-01-21 마이클 홀릭 아포모르핀의 글리코시드 및 오르토에스테르 글리코시드유도체들, 유사체들 및 그것의 용도
FR2864082B1 (fr) 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur

Also Published As

Publication number Publication date
FR2939436B1 (fr) 2010-12-17
EP2376496A2 (fr) 2011-10-19
TW201033218A (en) 2010-09-16
MY152276A (en) 2014-09-15
WO2010067007A2 (fr) 2010-06-17
AR074513A1 (es) 2011-01-19
JP2012511551A (ja) 2012-05-24
TN2011000243A1 (fr) 2012-12-17
MA32950B1 (fr) 2012-01-02
KR20110091534A (ko) 2011-08-11
MX337925B (es) 2016-03-28
HK1163096A1 (en) 2012-09-07
EA201170790A1 (ru) 2011-12-30
US8258298B2 (en) 2012-09-04
CN102307876B (zh) 2014-12-10
CO6390060A2 (es) 2012-02-29
ZA201104657B (en) 2012-09-26
ES2470666T3 (es) 2014-06-24
IL213379A0 (en) 2011-07-31
CL2011001398A1 (es) 2011-10-28
CA2746428A1 (fr) 2010-06-17
UA103643C2 (ru) 2013-11-11
BRPI0923238A2 (pt) 2016-01-26
JP5619768B2 (ja) 2014-11-05
AU2009326906B2 (en) 2016-05-26
MX2011006264A (es) 2011-11-04
SG172069A1 (en) 2011-07-28
EP2376496B1 (fr) 2014-03-12
ECSP11011100A (es) 2011-07-29
US20110275820A1 (en) 2011-11-10
HN2011001597A (es) 2013-09-09
AU2009326906A1 (en) 2011-06-30
NZ593342A (en) 2013-07-26
FR2939436A1 (fr) 2010-06-11
CN102307876A (zh) 2012-01-04
WO2010067007A3 (fr) 2011-07-07
NI201100116A (es) 2011-12-14
CR20110307A (es) 2011-09-21

Similar Documents

Publication Publication Date Title
AR091806A1 (es) Agente de curado para resina epoxi, composicion de resina epoxi y adhesivo para barrera de gas y laminado con barrera de gas
BR112017007124B8 (pt) Aparelho de empacotamento, uso do dito aparelho e processo de empacotar um produto disposto em um apoio que usa o dito aparelho
CO6160308A2 (es) Derivados de 2-aril-6-fenil-imidazo[1,2-a]piridinas su preparacion y su aplicacion en terapeutica
CO6160240A2 (es) Proceso de sintesis de macrolida
BRPI1006141B8 (pt) composições de anticorpo modificado, métodos para preparar e usar as mesmas
ES2570170T3 (es) Películas de poliéster resistentes a la hidrólisis
BR112012009135A2 (pt) composição polímera termoplástica
TW200604284A (en) Aliphatic-aromatic polyesters, and articles made therefrom
WO2008079787A8 (en) Glucokinase activators
BR112012024610A2 (pt) filme de poli (vinil-acetal) e seu uso
BRPI0803573A2 (pt) uso de ésteres 1-alquil-5-oxopirrolidina-3-carboxìlicos como inibidores de hidratos de gases com melhor biodegradabilidade
AR091348A1 (es) Agente de curado para resina epoxi, composicion de resina epoxi y adhesivo para barrera de gas y laminado con barrera de gas
AR063747A1 (es) Definilazetidinona sustituida con acido piperazina-1-sulfonico y que tiene propiedades farmacologicas mejoradas
PE20110836A1 (es) Sintesis de morfina-6-glucoronido
CU20150169A7 (es) Composiciones con cambio de fase mejorada que contienen acetato de sodio trihidratado o anhidro y proceso para su obtención
WO2011000489A3 (de) Neue ester und ihre verwendung
BRPI0816796A2 (pt) Composição antibacteriana compreendendo um agente antibacteriano baseado em ésteres de ácido graxo de ácido hidróxi carboxílico.
BR112013016637A2 (pt) processo para a preparação de derivados de 3-alquil-sulfinilbenzoíla
AR088713A1 (es) Composicion de cera diluida y paneles compuestos preparados con la misma
MX2015012605A (es) Procedimiento para preparar una composición de consomé.
CL2011000621A1 (es) Agente que contiene por lo menos un acido acilciclohexanodionacarboxilico y/o sus sales en combinacion con por lo menos un ester de acido acilciclohexanodionacarboxilico y su uso para mejorar el desarrollo de gramineas.
AR084112A1 (es) Carbodiimidas biobasadas, un procedimiento para su preparacion y su uso
RU2007122234A (ru) Древесина модифицированная эмукрилом (м или с)
WO2008063273A3 (en) Fluids having silicone groups and organic groups containing esters
TW200641088A (en) Organic light emitting materials and use thereof

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed